After big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPO By: San Francisco Business Times via Business Journals September 28, 2020 at 17:53 PM EDT Much of the team that led Alios — without a "g" — to aa $1.8 billion acquisition now is back with Aligos. Read More >>
